Aperture Sectors › Healthcare & Life Sciences › Quality, regulatory & safety
Quality, regulatory & safety funding
Quality, regulatory & safety
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
19 rounds, $239M raised by 17 companies, Jan 2, 2023 to Nov 14, 2026, 1% of Healthcare & Life Sciences capital. Top three companies: Qualifyze 23%, Ketryx 22%, Scarlet 21%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Qualifyze | Germany | $54M | 1 | — |
| Ketryx | United States | $53M | 2 | — |
| Scarlet | United Kingdom | $50M | 1 | — |
| Flinn | Austria | $27M | 2 | — |
| Dot Compliance | United States | $18M | 1 | — |
| ALIGNMT AI | United States | $6.5M | 1 | — |
| Selta Square | South Korea | $6.4M | 1 | — |
| Sware | United States | $6M | 1 | — |
| OnboardAI | United States | $5M | 1 | — |
| Shaperon | Japan | $4M | 1 | — |
| Cellbyte | Germany | $2.8M | 1 | — |
| PolicyEdge AI | United States | $2M | 1 | — |
| Quality Means Business | United States | $2M | 1 | — |
| FormlyAI | United States | $2M | 1 | — |
| DAIKI | Austria | $1.6M | 1 | — |
| Divine Technology | South Korea | $0 | 1 | — |
| Basil Systems | United States | $0 | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| Qualifyze | $54M | Series B | Sep 10, 2024 |
| Scarlet | $50M | Series B | Oct 12, 2026 |
| Ketryx | $39M | Series B | Sep 4, 2025 |
| Flinn | $20M | Series A | Feb 19, 2026 |
| Dot Compliance | $18M | Series B | Apr 16, 2024 |
| Ketryx | $14M | Series A | Dec 5, 2023 |
| Flinn | $6.7M | Seed | Sep 30, 2024 |
| ALIGNMT AI | $6.5M | Seed | Aug 28, 2025 |
| Selta Square | $6.4M | Series A | Jan 27, 2025 |
| Sware | $6M | Series B | Jun 6, 2024 |